Source: The Pharma Letter

Zosano Pharma: Zosano tanks as FDA rejects Qtrypta NDA

USA-based Zosano Pharma took another nosedive, with its shares falling 28% pre-market yesterday after...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Steven Lo's photo - President & CEO of Zosano Pharma

President & CEO

Steven Lo

CEO Approval Rating

83/100

Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Read more